Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
Clinical trial NCT04070768 · COMPLETED
Trial details
- NCT number
- NCT04070768
- Sponsor
- John Quigley
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2023-10-12
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.